UNI - EN REPORT No
UNI - EN REPORT No60/2019
Sopharma AD (the “Company”) notifies that for September 2019 the Company recorded an increase in sales of 31% compared to the same month of 2018, incl. 5% decrease in sales for the domestic market and 66% increase in export sales.
In the first nine months of 2019 the revenues from sales of production increased by 2% compared to the same period of 2018, incl. 9% decrease in domestic sales and 10% increase in export sales.